Pharmacovigilance is the science of collecting, detecting, assessing, and monitoring data of drugs in order to minimize or prevent adverse effects. Pharmacovigilance, modernization and evolution of safety pharmacology, employs sophisticated state of the art approaches in the collection and analyses of data for therapeutics under development and for post-marketing surveillance of pharmaceutical products. Pharmacovigilance offers the promise of significant beneficial improvements in human health by providing safer, more effective and individually tailored therapeutics.
Loyola’s Department of Molecular Pharmacology & Neuroscience offers a 12-credit certificate program in Pharmacovigilance which can be completed in 1-year (full-time) or 2-years (part-time). This program is especially well suited for individuals who are planning careers in the pharmaceutical industry, public health sciences, or biomedical research. The certificate program is also suited for physicians, nurses, and scientists in epidemiology or therapeutic-related fields. The program covers all aspects of Pharmacovigilance, related drug development and regulatory topics, and the ethics associate with these endeavors. Courses involve executives and expert scientists from the pharmaceutical industry who are world leaders in these areas.
All courses consist of Asynchronous lectures and synchronous course meetings (early evening) and are flexible to allow students to take the courses from home and around daytime obligations.